AssetMark Inc
GSK icon

AssetMark Inc’s GSK GSK Stock Holding History

AssetMark Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9M Buy
551,436
+70,800
+15% +$3.74M 0.05% 288
2026
Q1 		$26.5M Buy
480,636
+47,772
+11% +$2.59M 0.05% 276
2025
Q4 		$21.2M Buy
432,864
+69,404
+19% +$3.24M 0.04% 320
2025
Q3 		$15.7M Buy
363,460
+86,081
+31% +$3.36M 0.03% 354
2025
Q2 		$10.7M Buy
277,379
+175,476
+172% +$6.71M 0.03% 389
2025
Q1 		$3.95M Buy
101,903
+26,754
+36% +$979K 0.01% 562
2024
Q4 		$2.54M Buy
75,149
+55,354
+280% +$1.99M 0.01% 654
2024
Q3 		$809K Buy
19,795
+11,448
+137% +$468K ﹤0.01% 820
2024
Q2 		$321K Buy
8,347
+4,315
+107% +$182K ﹤0.01% 928
2024
Q1 		$173K Buy
4,032
+1,450
+56% +$59.8K ﹤0.01% 964
2023
Q4 		$95.7K Buy
2,582
+2,430
+1,599% +$87.2K ﹤0.01% 1047
2023
Q3 		$5.51K Sell
152
-5,867
-97% -$208K ﹤0.01% 1381
2023
Q2 		$215K Sell
6,019
-1,252
-17% -$44.9K ﹤0.01% 836
2023
Q1 		$259K Buy
7,271
+5,030
+224% +$176K ﹤0.01% 799
2022
Q4 		$78.7K Sell
2,241
-8,297
-79% -$276K ﹤0.01% 953
2022
Q3 		$310K Buy
10,538
+2,818
+37% +$107K ﹤0.01% 720
2022
Q2 		$420K Buy
7,720
+2,314
+43% +$128K ﹤0.01% 650
2022
Q1 		$294K Buy
5,406
+1,971
+57% +$107K ﹤0.01% 692
2021
Q4 		$189K Buy
3,435
+528
+18% +$27.5K ﹤0.01% 711
2021
Q3 		$139K Sell
2,907
-3,688
-56% -$185K ﹤0.01% 614
2021
Q2 		$328K Sell
6,595
-29,368
-82% -$1.41M ﹤0.01% 515
2021
Q1 		$1.6M Sell
35,963
-103,136
-74% -$4.68M 0.01% 320
2020
Q4 		$6.4M Buy
139,099
+5,153
+4% +$237K 0.04% 241
2020
Q3 		$6.3M Buy
133,946
+6,723
+5% +$337K 0.04% 228
2020
Q2 		$6.49M Buy
127,223
+11,549
+10% +$593K 0.05% 220
2020
Q1 		$5.48M Sell
115,674
-2,056
-2% -$110K 0.05% 208
2019
Q4 		$6.92M Buy
117,730
+111,703
+1,853% +$6.21M 0.05% 229
2019
Q3 		$322K Buy
6,027
+261
+5% +$13.4K ﹤0.01% 418
2019
Q2 		$288K Buy
5,766
+2,868
+99% +$144K ﹤0.01% 424
2019
Q1 		$151K Sell
2,898
-40
-1% -$2K ﹤0.01% 493
2018
Q4 		$140K Buy
2,938
+2,564
+686% +$126K ﹤0.01% 498
2018
Q3 		$19K Buy
374
+52
+16% +$2.64K ﹤0.01% 938
2018
Q2 		$16K Buy
322
+7
+2% +$353 ﹤0.01% 971
2018
Q1 		$15K Sell
315
-162
-34% -$7.54K ﹤0.01% 978
2017
Q4 		$21K Buy
477
+31
+7% +$1.43K ﹤0.01% 989
2017
Q3 		$23K Sell
446
-110,360
-100% -$5.6M ﹤0.01% 898
2017
Q2 		$5.97M Sell
110,806
-33,657
-23% -$1.79M 0.08% 176
2017
Q1 		$7.61M Buy
144,463
+2,409
+2% +$122K 0.1% 159
2016
Q4 		$6.84M Buy
142,054
+12,514
+10% +$618K 0.1% 155
2016
Q3 		$6.98M Sell
129,540
-111,530
-46% -$6.12M 0.11% 138
2016
Q2 		$13.1M Buy
241,070
+11,708
+5% +$617K 0.22% 103
2016
Q1 		$11.6M Buy
229,362
+31,297
+16% +$1.56M 0.2% 97
2015
Q4 		$9.99M Buy
198,065
+58,504
+42% +$2.98M 0.19% 102
2015
Q3 		$6.71M Buy
139,561
+139,491
+199,273% +$7.26M 0.14% 108
2015
Q2 		$4K Buy
+70
New +$3.94K ﹤0.01% 591

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

AssetMark Inc's GSK Position: Q2 2026 in Review

AssetMark Inc increased its GSK (GSK) stake by 15% in Q2 2026, buying an estimated $3.74M and bringing the position to 551,436 shares worth $28.9M. The position accounts for 0.05% of the portfolio, ranked #288.

AssetMark Inc first reported a position in GSK in Q2 2015 and has held it in 45 quarters since. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • AssetMark Inc held 551,436 shares of GSK worth $28.9M as of Q2 2026.
  • AssetMark Inc bought 70,800 GSK shares in Q2 2026, an estimated $3.74M.
  • GSK made up 0.05% of AssetMark Inc's portfolio in Q2 2026, its #288 holding.
  • AssetMark Inc first reported a position in GSK in Q2 2015 and has held it in 45 quarters since.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.